Morris D - Search Results

1

Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma.

Suo A, Chan Y, Beaulieu C, Kong S, Cheung WY, Monzon JG, Smylie M, Walker J, Morris D, Cheng T. Suo A, et al. Among authors: morris d. Oncologist. 2020 May;25(5):438-446. doi: 10.1634/theoncologist.2019-0674. Epub 2020 Feb 12. Oncologist. 2020. PMID: 32048768 Free PMC article.

2

Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation.

Thirukkumaran CM, Luider JM, Stewart DA, Cheng T, Lupichuk SM, Nodwell MJ, Russell JA, Auer IA, Morris DG. Thirukkumaran CM, et al. Blood. 2003 Jul 1;102(1):377-87. doi: 10.1182/blood-2002-08-2508. Epub 2003 Mar 13. Blood. 2003. PMID: 12637331 Free article.

3

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.

Cheng T, Forsyth P, Chaudhry A, Morris D, Glück S, Russell JA, Stewart DA. Cheng T, et al. Among authors: morris d. Bone Marrow Transplant. 2003 Apr;31(8):679-85. doi: 10.1038/sj.bmt.1703917. Bone Marrow Transplant. 2003. PMID: 12692608

4

A network approach to developing immuno-oncology combinations in Canada.

Higenell V, Fajzel R, Batist G, Cheema PK, McArthur HL, Melosky B, Morris D, Petrella TM, Sangha R, Savard MF, Sridhar SS, Stagg J, Stewart DJ, Verma S. Higenell V, et al. Among authors: morris d. Curr Oncol. 2019 Apr;26(2):73-79. doi: 10.3747/co.26.4393. Epub 2019 Apr 1. Curr Oncol. 2019. PMID: 31043804 Free PMC article.

5

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors.

Meyers DE, Stukalin I, Vallerand IA, Lewinson RT, Suo A, Dean M, North S, Pabani A, Cheng T, Heng DYC, Bebb DG, Morris DG. Meyers DE, et al. Among authors: morris dg. Cancers (Basel). 2019 Nov 2;11(11):1713. doi: 10.3390/cancers11111713. Cancers (Basel). 2019. PMID: 31684111 Free PMC article.

6

Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.

Lewinson RT, Meyers DE, Vallerand IA, Suo A, Dean ML, Cheng T, Bebb DG, Morris DG. Lewinson RT, et al. Among authors: morris dg. J Am Acad Dermatol. 2021 Jan;84(1):183-185. doi: 10.1016/j.jaad.2020.04.069. Epub 2020 Apr 22. J Am Acad Dermatol. 2021. PMID: 32334053 No abstract available.

7

Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors.

Sander MS, Stukalin I, Vallerand IA, Goutam S, Ewanchuk BW, Meyers DE, Pabani A, Morris DG, Heng DYC, Cheng T. Sander MS, et al. Cancer Med. 2021 Apr;10(8):2618-2626. doi: 10.1002/cam4.3784. Epub 2021 Mar 16. Cancer Med. 2021. PMID: 33724676 Free PMC article.

8

Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials.

Gan CL, Stukalin I, Meyers DE, Dudani S, Grosjean HAI, Dolter S, Ewanchuk BW, Goutam S, Sander M, Wells C, Pabani A, Cheng T, Monzon J, Morris D, Basappa NS, Pal SK, Wood LA, Donskov F, Choueiri TK, Heng DYC. Gan CL, et al. Among authors: morris d. Eur J Cancer. 2021 Jul;151:115-125. doi: 10.1016/j.ejca.2021.04.004. Epub 2021 May 8. Eur J Cancer. 2021. PMID: 33975059 Free article.

9

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database.

Grosjean HAI, Dolter S, Meyers DE, Ding PQ, Stukalin I, Goutam S, Kong S, Chu Q, Heng DYC, Bebb DG, Morris DG, Cheung WY, Pabani A. Grosjean HAI, et al. Among authors: morris dg. Curr Oncol. 2021 Oct 18;28(5):4213-4222. doi: 10.3390/curroncol28050357. Curr Oncol. 2021. PMID: 34677275 Free PMC article.

10

The impact of population-based EGFR testing in non-squamous metastatic non-small cell lung cancer in Alberta, Canada.

Brenner DR, O'Sullivan DE, Jarada TN, Yusuf A, Boyne DJ, Mather CA, Box A, Morris DG, Cheung WY, Mirza I. Brenner DR, et al. Lung Cancer. 2023 Jan;175:60-67. doi: 10.1016/j.lungcan.2022.11.017. Epub 2022 Nov 25. Lung Cancer. 2023. PMID: 36463730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,629 results

Search Page

Filters